Artia Global Partners as of March 31, 2026
Portfolio Holdings for Artia Global Partners
Artia Global Partners holds 49 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insmed Com Par $.01 (INSM) | 29.7 | $149M | 908k | 163.52 | |
| Abivax Sa Sponsored Ads (ABVX) | 13.4 | $67M | 601k | 111.35 | |
| Eli Lilly & Co. (LLY) | 7.0 | $35M | 38k | 919.77 | |
| Trevi Therapeutics (TRVI) | 4.8 | $24M | 2.0M | 11.93 | |
| Argenx Se Sponsored Adr (ARGX) | 4.3 | $22M | 30k | 730.25 | |
| Astrazeneca Ord (AZN) | 3.8 | $19M | 95k | 197.22 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 3.2 | $16M | 504k | 32.01 | |
| Dianthus Therapeutics (DNTH) | 2.7 | $14M | 163k | 83.92 | |
| Revolution Medicines (RVMD) | 2.4 | $12M | 125k | 97.25 | |
| Ionis Pharmaceuticals (IONS) | 2.2 | $11M | 144k | 75.09 | |
| Moderna Call Option (MRNA) | 2.0 | $10M | 200k | 50.80 | |
| Eyepoint Com New (EYPT) | 2.0 | $9.9M | 767k | 12.89 | |
| Quest Diagnostics Incorporated (DGX) | 1.6 | $8.0M | 41k | 195.98 | |
| Alumis (ALMS) | 1.4 | $7.2M | 325k | 22.03 | |
| Viking Therapeutics (VKTX) | 1.2 | $5.9M | 181k | 32.54 | |
| Merck & Co (MRK) | 1.1 | $5.6M | 47k | 120.29 | |
| Terns Pharmaceuticals (TERN) | 1.1 | $5.5M | 105k | 52.72 | |
| Johnson & Johnson (JNJ) | 1.1 | $5.5M | 23k | 244.44 | |
| Sionna Therapeutics (SION) | 1.0 | $4.8M | 120k | 40.09 | |
| Scholar Rock Hldg Corp (SRRK) | 0.9 | $4.7M | 96k | 49.16 | |
| Rapport Therapeutics (RAPP) | 0.9 | $4.3M | 139k | 31.29 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.8 | $4.1M | 18k | 228.73 | |
| Belite Bio Sponsored Ads (BLTE) | 0.8 | $4.0M | 25k | 159.44 | |
| Xenon Pharmaceuticals (XENE) | 0.8 | $3.8M | 65k | 58.15 | |
| Mineralys Therapeutics (MLYS) | 0.7 | $3.7M | 138k | 27.09 | |
| Roivant Sciences SHS (ROIV) | 0.7 | $3.6M | 130k | 27.70 | |
| Palisade Bio (PALI) | 0.7 | $3.5M | 2.0M | 1.75 | |
| Biogen Idec (BIIB) | 0.7 | $3.4M | 18k | 183.33 | |
| Prokidney Corp Shs Cl A (PROK) | 0.6 | $3.2M | 1.8M | 1.79 | |
| Abbvie (ABBV) | 0.6 | $3.2M | 15k | 217.49 | |
| United Therapeutics Corporation (UTHR) | 0.6 | $3.0M | 5.0k | 592.98 | |
| Bright Minds Biosciences Com New (DRUG) | 0.6 | $2.8M | 38k | 72.97 | |
| Protagonist Therapeutics (PTGX) | 0.5 | $2.4M | 23k | 105.40 | |
| Soleno Therapeutics (SLNO) | 0.5 | $2.3M | 69k | 33.48 | |
| Brightspring Health Svcs (BTSG) | 0.5 | $2.3M | 54k | 42.61 | |
| Travere Therapeutics (TVTX) | 0.4 | $2.1M | 71k | 29.71 | |
| Edgewise Therapeutics (EWTX) | 0.4 | $2.1M | 66k | 31.50 | |
| Celcuity (CELC) | 0.4 | $1.8M | 16k | 114.14 | |
| Bridgebio Pharma (BBIO) | 0.3 | $1.5M | 20k | 74.26 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 0.3 | $1.4M | 29k | 48.15 | |
| Cytokinetics Com New (CYTK) | 0.2 | $1.1M | 16k | 65.91 | |
| Enliven Therapeutics (ELVN) | 0.2 | $819k | 21k | 39.20 | |
| Praxis Precision Medicines I Com New (PRAX) | 0.2 | $806k | 2.5k | 322.19 | |
| Tenax Therapeutics Com New (TENX) | 0.1 | $673k | 42k | 15.99 | |
| Kodiak Sciences (KOD) | 0.1 | $649k | 17k | 38.12 | |
| Nuvalent Inc-a (NUVL) | 0.1 | $502k | 4.9k | 102.45 | |
| Apogee Therapeutics (APGE) | 0.1 | $495k | 5.9k | 84.17 | |
| Avalo Therapeutics Com New (AVTX) | 0.1 | $433k | 29k | 14.93 | |
| Pepgen (PEPG) | 0.1 | $363k | 205k | 1.77 |
